These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7343033)

  • 21. [Our experience with timolol in the treatment of open-angle glaucoma].
    Bec P; Arne JL; Secheyron P; Fontan P; Mialhe JP
    Bull Soc Ophtalmol Fr; 1980 Mar; 80(3):295-8. PubMed ID: 7363395
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of 1.5% timolol maleate on intraocular pressure.
    Ritch R; Hargett NA; Podos SM
    Acta Ophthalmol (Copenh); 1978 Feb; 56(1):6-10. PubMed ID: 345735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additive effect of epinephrine to timolol therapy in primary open angle glaucoma.
    Cyrlin MN; Thomas JV; Epstein DL
    Arch Ophthalmol; 1982 Mar; 100(3):414-8. PubMed ID: 7065957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Timolol and facility of outflow.
    Zimmerman TJ; Harbin R; Pett M; Kaufman HE
    Invest Ophthalmol Vis Sci; 1977 Jul; 16(7):623-4. PubMed ID: 873723
    [No Abstract]   [Full Text] [Related]  

  • 25. Timolol and acetazolamide. A study of concurrent administration.
    Kass MA; Korey M; Gordon M; Becker B
    Arch Ophthalmol; 1982 Jun; 100(6):941-2. PubMed ID: 7092633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timolol maleate--a new glaucoma medication?
    Zimmerman TJ
    Invest Ophthalmol Vis Sci; 1977 Aug; 16(8):687-8. PubMed ID: 407171
    [No Abstract]   [Full Text] [Related]  

  • 27. [Proxodolol, a new domestic preparation for lowering intraocular pressure in glaucoma].
    Ermakova VN; Iuzhakov SD; Mashkovskiĭ MD; Kolomoĭtseva EM
    Vestn Oftalmol; 1995; 111(2):4-7. PubMed ID: 7645180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
    Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzałkiewicz A; Zaleska-Zmijewska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
    Klin Oczna; 2004; 106(1-2 Suppl):241-2. PubMed ID: 15510513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of the intraocular pressure lowering effect of timolol and dipivalyl epinephrine.
    Frumar KD; McGuinness R
    Trans Ophthalmol Soc N Z; 1981; 33():27-9. PubMed ID: 7020221
    [No Abstract]   [Full Text] [Related]  

  • 30. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
    Walters TR; DuBiner HB; Carpenter SP; Khan B; VanDenburgh AM;
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twenty-four-hour intraocular pressure control with the travoprost/timolol maleate fixed combination compared with travoprost when both are dosed in the evening in primary open-angle glaucoma.
    Konstas AG; Mikropoulos D; Haidich AB; Ntampos KS; Stewart WC
    Br J Ophthalmol; 2009 Apr; 93(4):481-5. PubMed ID: 19019932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of timolol solution once daily versus timolol gel in treating elevated intraocular pressure.
    Stewart WC; Leland TM; Cate EA; Stewart JA
    J Glaucoma; 1998 Dec; 7(6):402-7. PubMed ID: 9871862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Cvenkel B; Stewart JA; Nelson LA; Stewart WC
    Curr Eye Res; 2008 Feb; 33(2):163-8. PubMed ID: 18293187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Timolol maleate in the treatment of chronic open-angle glaucoma].
    Valle O; Klemetti A; Takki KK
    Duodecim; 1981; 97(13):947-56. PubMed ID: 7032878
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of timolol maleate and acetazolamide on the rate of aqueous formation in normal human subjects.
    Dailey RA; Brubaker RF; Bourne WM
    Am J Ophthalmol; 1982 Feb; 93(2):232-7. PubMed ID: 7039328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
    J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the effects of 0.005% latanoprost and fixed combination dorzolamide/timolol on retrobulbar haemodynamics in previously untreated glaucoma patients.
    Martínez A; Sánchez M
    Curr Med Res Opin; 2006 Jan; 22(1):67-73. PubMed ID: 16393432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.
    Schuman JS; Katz GJ; Lewis RA; Henry JC; Mallick S; Wells DT; Sullivan EK; Landry TA; Bergamini MV; Robertson SM
    Am J Ophthalmol; 2005 Aug; 140(2):242-50. PubMed ID: 16086946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of chronically administered timolol on aqueous humor flow in patients with glaucoma.
    Brubaker RF; Nagataki S; Bourne WM
    Ophthalmology; 1982 Mar; 89(3):280-3. PubMed ID: 7088511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.